- Home
- HURA vs CTAA Comparison
HURA vs CTAA Comparison
Compare HURA & CTAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | HURA | CTAA |
|---|---|---|
| Founded | 2009 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Blank Checks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.5M | 166.0M |
| IPO Year | 2010 | 2026 |
Fundamental Metrics
Financial Performance| Metric | HURA | CTAA |
|---|---|---|
| Price | $1.76 | $10.00 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.04 | N/A |
| AVG Volume (30 Days) | ★ 211.8K | 109.5K |
| Earning Date | 11-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.93 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.41 | $9.88 |
| 52 Week High | $3.43 | $10.00 |
Technical Indicators
Market Signals| Indicator | HURA | CTAA |
|---|---|---|
| Relative Strength Index (RSI) | 34.17 | 58.54 |
| Support Level | $1.27 | $9.91 |
| Resistance Level | $1.83 | N/A |
| Average True Range (ATR) | 0.10 | 0.02 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 14.93 | 90.00 |
Price Performance
Historical ComparisonAbout HURA TuHURA Biosciences Inc.
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
About CTAA ClearThink 1 Acquisition Corp. Class A Ordinary Shares
ClearThink 1 Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.